Moreover, eight categories of psychiatric AEs, namely, nervousness (ROR = 1.97, 95% CI = 1.852.11), stress (ROR = 1.28, 95% CI = 1.191.38), eating disorder (ROR = 1.57, 95% CI = 1.401.77), fear of injection (ROR = 1.96, 95% CI = 1.602.40), sleep disorder due to general medical conditioninsomnia type (ROR = 2.01, 95% CI = 1.602.52), binge eating (ROR = 2.70, 95% CI = 1.754.16), fear of eating (ROR 3.35, 95% CI = 1.656.78), and self-induced vomiting (ROR = 3.77, 95% CI = 1.778.03), were defined as GLP-1 RA-related psychiatric AEs through disproportionality analysis
How do you compare one 1 Vial Tanning Injection Starter Kit option with another
Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary NEW YORK, April 9, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Company's newest oral GLP-1 innovation on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s
The formula comes designed to work along with other fat-burning health supplements